CME Group, the world’s leading derivatives marketplace, today announced that it will launch options on its existing U.S. Dollar / Offshore Chinese Renminbi (USD/CNH) futures on April 3, pending regulatory review.
FDA Signals Unclear Clinical Benefits Of Ardelyx’s Kidney Disease Candidate
The FDA’s Cardiovascular and Renal Drugs Advisory Committee is scheduled to meet Wednesday, November 16, to review Ardelyx Inc (NASDAQ:ARDX) Xphozah (tenapanor)…